Back
5 MIN READ
As the cannabis industry continues to expand, new opportunities continue to emerge.
From private placements to publicly traded companies, there are a number of avenues available for potential and current cannabis investors. Given the nature of the industry, though, many or do not understand or are aware of these opportunities.
The quickest and easiest way to invest in a cannabis company is through the stock market. An investor can invest as much or as little as they want and the cost per transaction is usually less than $10. There is no required hold period for the investment and the market to sell it on typically has high liquidity.
The process of investing in a private company is much different than that for investing in a public company. These investments have a larger minimum (at least $2,500) and typically are restricted for at least four months. During this time, an investor is not able to sell their investment.
Although private companies require larger investments and have varying restrictions, the returns are worth the wait.
Undervalued Public Opportunities
We continue to see value in a number of publicly traded companies levered to the cannabis industry. From biotech to cannabis producers, we believe that several stocks under our coverage represent attractive investments as they remain undervalued.
Arcturus Growthstar Technologies (AGSTF)and Reliq Healthcare (RQHTF), two companies we have been monitoring, have fallen 3% and 10%, respectively, over the last month despite favorable company developments. Arcturus is currently conducting a private offering at $0.25 a share while the stock trades at $0.34. To access information about this offering contact support@mushroomstocks.com
OrganiGram (OGRMF), another company we are favorable on, has fallen more than 13% in the last month and we believe that this Canadian licensed producer remains undervalued when compared to its peers. Later this month, OrganiGram will report earnings and we expect to see these to be very favorable. Keep an eye on this one!
The Next Big Canadian IPO
The Green Organic Dutchman is a company we have been favorable on as the company prepares to go public over the next year. This licensed medical cannabis producer is allowed to cultivate medical marijuana under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The Green Organic operates out of its facilities in Ancaster, Ontario.
The company is backed by the same financial team that brought together OrganiGram and Emblem Cannabis. The company cultivates high-quality organic medical cannabis in small batches using craft growing, guided by all natural and organic principles. The Green Organic Dutchman expects to generate $90 million by 2018.
Click here to read our recent article on Green Organic Dutchman
A Crowdfunding Cannabis Play
Green Leaf Investment Fund operates under the Regulation A+ model and is a real estate firm focused on the emerging cannabis industry. The company owns budproperties.com and provides warehouse and greenhouse properties to licensed cannabis businesses in the United States.
Green Leaf operates under the belief that the real money in the cannabis industry is in the real estate sector and that when it comes to long-term success this aspect of the business is the most crucial.
Demand for properly zoned cannabis properties continues to climb and add millions of dollars in value to a suitable location. Green Leaf has been executing on its plan to build a robust portfolio of suitably zoned cannabis properties. The company has identified several properties that are ideally suited for the cannabis industry.
Green Leaf’s team includes seasoned commercial real estate executives that have significant experience under their belts. Since entering the real estate industry, Green Leaf’s team has completed hundreds of transactions totaling over $3 billion in business.
Join Mushroomstocks and Capitalize on the Rapidly Growing Cannabis Industry…
Important Investor Disclosures
Disclosure. Compensated Affiliate. This report was authored by and is property of StoneBridge Partners LLC. All information and data relied upon in drafting this report is publicly available. The author believes and considers its sources to be reliable, but does not guarantee the accuracy or completeness of any information contained in this report. Any and all information, data, analyses and opinions are provided for informational purposes only and is not intended, in any manner, as investment advice. Any projections or other information generated by StoneBridge Partners LLC regarding the likelihood of various investment outcomes are hypothetical in nature, do not reflect actual investment results, and are not guarantees of future results. None of the material contained in this report is intended as a solution or offer to sell or purchase a specific stock or any other investment. This report is not directed to, or intended for distribution or use by, any person or entity that is a citizen, resident or located in any municipality, state, country or other jurisdiction where the distribution, publication, availability, or use of this report is contrary to any governing law or regulation. The securities discussed in this report may not be eligible for purchase and/or sale in certain jurisdictions or by particular individuals. It is important that you check any and all governing laws and/or regulations that may be applicable in your jurisdiction. Investing in securities of issuers organized outside of the United States, including ADRs, entail certain risks. The securities of non-United States issuers may not be registered with, nor be subject to the reporting requirements of the United States Securities and Exchange Commission. Please contact a Financial Advisor for professional advice regarding any and all securities investments. This report is intended for informational purposes only. StoneBridge Partners LLC’s officers, directors, employees, affiliates, or subsidiaries may have positions in securities covered by StoneBridge Partners LLC. StoneBridge Partners LLC receives compensation from the company and/or has a position in the securities mentioned in this report
All good -- no spamming here.
Comments